[MAP kinase signal pathway in hyperglycemia-induced congenital neural tube defects]
Bi-Liang Chen1, Xiang-Dong Ma, Xiao-Yan Xin
1Department of Obstetrics & Gynecology, Xijing Hospital, Fourth Military Medical University, Xi'an 710 033, China. gynobs@fmmu.edu.cn
Abstract:
The aim of the present study was to determine molecular mechanism in hyperglycemia-induced congenital neural tube defects and the its potential pharmacologic rescuing agents. In order to explore these questions, six study groups of Sprague-Dawley rats were employed: Group 1 was normal control rats with normal diet; group 2 represented streptozotocin (STZ) -induced diabetic rats with congenital neural tube defects in offspring; group 3 included STZ-induced diabetic rats with normal offspring; groups 4,5 and 6 included rats exposed to the same STZ-induced diabetic condition, but receiving daily oral supplementation of 80 microg/mL of the sodium salt of arachidonic acid (AA), 400mg of vitamin E and a cocktail of a polyunsaturated fatty acid (safflower oil) plus an antioxidant ( vitamin E) respectively. Yolk sac cells were harvested at gestational day 12 from each rat group. Changes in MAPK signaling pathways were detected by western blot analysis using special antibodies directed against phosphorylated forms of extracellular signal regulated kinase (ERK), Jun N-terminal/stress-activated protein kinase (JNK/SAPK). Furthermore, activity of RAF-1, an upstream kinase in ERK1/2 signaling cascade, was evaluated by immunoprecipitation assay. The results showed that in yolk sac cells in embryopathic offspring from experimentally-induced diabetic rats, activities of ERK1/2 were dramatically decreased (group 2). Consisted with these observation, reduction in RAF-1 kinase activity could be discerned in these diabetic yolk sac cells. In contrast, activities of JNK1/2 were significantly increased in yolk sac cells of group 2. Under rescuing circumstance,activations of ERK1/2 and RAF-1 were increased, and JNK1/2 were decreased. MAP kinase signal pathway plays a very important role in hyperglycemia induced neural tube defects. The supplementation of polyunsaturated fatty acid arachidonic acid, and antioxidant vitamin E rescued conceptuses from diabetic embryopathy by triggering a restoration of normal membrane signaling pathways.
Insights
Hyperglycemia in diabetic rats causes neural tube defects by altering MAPK signaling pathways. Supplementation with arachidonic acid and vitamin E restored these pathways, rescuing offspring from defects.
Area of Science:
- Developmental biology
- Molecular endocrinology
- Neuroscience
Context:
- Hyperglycemia during pregnancy is a known risk factor for congenital anomalies, particularly neural tube defects (NTDs).
- The precise molecular mechanisms underlying hyperglycemia-induced NTDs remain incompletely understood.
- Mitogen-activated protein kinase (MAPK) signaling pathways are crucial for embryonic development.
Purpose:
- To elucidate the molecular mechanisms of hyperglycemia-induced NTDs in Sprague-Dawley rats.
- To investigate the potential of pharmacological agents, specifically arachidonic acid (AA) and vitamin E, in rescuing these defects.
Summary:
- Streptozotocin (STZ)-induced diabetes in pregnant rats led to decreased extracellular signal-regulated kinase (ERK1/2) and RAF-1 activity, alongside increased Jun N-terminal kinase (JNK1/2) activity in yolk sac cells of affected offspring.
- Supplementation with arachidonic acid (AA) and vitamin E reversed these MAPK pathway alterations, restoring normal signaling.
- These findings indicate that dysregulation of MAPK signaling is a key mechanism in diabetic embryopathy leading to NTDs.
Impact:
- Identifies specific molecular targets within the MAPK pathway involved in hyperglycemia-induced NTDs.
- Demonstrates the therapeutic potential of arachidonic acid and vitamin E as rescuing agents for diabetic embryopathy.
- Provides a foundation for developing novel strategies to prevent congenital defects in diabetic pregnancies.
Related Concept Videos
PI3K/mTOR/AKT Signaling Pathway
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
MAPK Signaling Cascades
cAMP-dependent Protein Kinase Pathways


